Total Clarity Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Total Clarity Wealth Management's BIIB Position: Q3 2022 in Review
Total Clarity Wealth Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 160 shares — an estimated $33K sold.
Total Clarity Wealth Management first reported a position in BIIB in Q4 2019 and held it in 5 quarters. The position peaked at $40K in Q4 2019. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.
- Total Clarity Wealth Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
- Total Clarity Wealth Management sold 160 Biogen shares in Q3 2022, an estimated $33K.
- Total Clarity Wealth Management first reported a position in Biogen in Q4 2019 and held it in 5 quarters.
- Total Clarity Wealth Management's Biogen position peaked at $40K in Q4 2019.
- 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.
Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.